These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12877644)

  • 21. Technosphere insulin: an inhaled prandial insulin product.
    Neumiller JJ; Campbell RK
    BioDrugs; 2010 Jun; 24(3):165-72. PubMed ID: 20462282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.
    Quattrin T; Bélanger A; Bohannon NJ; Schwartz SL;
    Diabetes Care; 2004 Nov; 27(11):2622-7. PubMed ID: 15504996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhaled insulin, new perspective for insulin therapy].
    Radermecker RP; Sélam JL
    Rev Med Liege; 2005; 60(5-6):355-60. PubMed ID: 16035294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients.
    Brunner GA; Balent B; Ellmerer M; Schaupp L; Siebenhofer A; Jendle JH; Okikawa J; Pieber TR
    Diabetologia; 2001 Mar; 44(3):305-8. PubMed ID: 11317660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newer devices and improved formulations of inhaled insulin.
    Rashid J; Absar S; Nahar K; Gupta N; Ahsan F
    Expert Opin Drug Deliv; 2015 Jun; 12(6):917-28. PubMed ID: 25485886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unlocking the opportunity of tight glycaemic control. Innovative delivery of insulin via the lung.
    Patton JS
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S5-8. PubMed ID: 16135136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: clinical efficacy.
    Scherbaum WA
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S9-13. PubMed ID: 16135137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Future prospect of insulin inhalation for diabetic patients: The case of Afrezza versus Exubera.
    Al-Tabakha MM
    J Control Release; 2015 Oct; 215():25-38. PubMed ID: 26222134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial.
    Fineberg SE; Kawabata T; Finco-Kent D; Liu C; Krasner A
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3287-94. PubMed ID: 15741258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes.
    Rosenstock J; Cefalu WT; Hollander PA; Belanger A; Eliaschewitz FG; Gross JL; Klioze SS; St Aubin LB; Foyt H; Ogawa M; Duggan WT
    Diabetes Care; 2008 Sep; 31(9):1723-8. PubMed ID: 18535196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled human insulin: an inspiration for patients with diabetes mellitus?
    Davidson MB; Mehta AE; Siraj ES
    Cleve Clin J Med; 2006 Jun; 73(6):569-78. PubMed ID: 16784157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of phase 2 studies utilizing the AIR particle technology in the delivery of human insulin inhalation powder versus subcutaneous regular or lispro insulin in subjects with type 1 or type 2 diabetes.
    Ellis SL; Gemperline KA; Garg SK
    Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S48-56. PubMed ID: 17563304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of inhaled insulin therapy for diabetes mellitus.
    Siddiqui NI
    Mymensingh Med J; 2007 Jul; 16(2):237-45. PubMed ID: 17703168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: safety.
    Brain JD
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S14-8. PubMed ID: 16135134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technosphere insulin: inhaled prandial insulin.
    Setji TL; Hong BD; Feinglos MN
    Expert Opin Biol Ther; 2016; 16(1):111-7. PubMed ID: 26567896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhaled insulin in diabetes mellitus.
    Royle P; Waugh N; McAuley L; McIntyre L; Thomas S
    Cochrane Database Syst Rev; 2003; (3):CD003890. PubMed ID: 12917994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrasubject variability of inhaled insulin in type 1 diabetes: a comparison with subcutaneous insulin.
    Kapitza C; Hompesch M; Scharling B; Heise T
    Diabetes Technol Ther; 2004 Aug; 6(4):466-72. PubMed ID: 15321001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary insulin administration using the AERx insulin diabetes system.
    Thipphawong J; Otulana B; Clauson P; Okikawa J; Farr SJ
    Diabetes Technol Ther; 2002; 4(4):499-504. PubMed ID: 12396744
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhaled insulin: too soon to be forgotten?
    Zarogoulidis P; Papanas N; Kouliatsis G; Spyratos D; Zarogoulidis K; Maltezos E
    J Aerosol Med Pulm Drug Deliv; 2011 Oct; 24(5):213-23. PubMed ID: 21689020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled micronized crystalline human insulin using a dry powder inhaler: dose-response and time-action profiles.
    Rave K; Nosek L; Heinemann L; Gonzales C; Ernest CS; Chien J; Muchmore D
    Diabet Med; 2004 Jul; 21(7):763-8. PubMed ID: 15209771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.